|
🐜
|
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
20 auth.
Y. Natkunam,
P. Farinha,
E. Hsi,
C. Hans,
R. Tibshirani,
L. Sehn,
J. Connors,
D. Gratzinger,
M. Rosado,
Shuchun Zhao,
...
B. Pohlman,
Nicholas Wongchaowart,
M. Bast,
A. Avigdor,
G. Schiby,
A. Nagler,
G. Byrne,
R. Levy,
R. Gascoyne,
I. Lossos
|
7 |
2008 |
7
🐜
|
|
🐜
|
A congenital neutrophil defect syndrome associated with mutations in VPS45.
32 auth.
T. Vilboux,
A. Lev,
M. Malicdan,
A. Simon,
Päivi M. Järvinen,
T. Racek,
J. Puchalka,
R. Sood,
Blake Carrington,
Kevin Bishop,
J. Mullikin,
M. Huizing,
B. Garty,
E. Eyal,
B. Wolach,
...
R. Gavrieli,
A. Toren,
M. Soudack,
Osama M Atawneh,
T. Babushkin,
G. Schiby,
A. Cullinane,
C. Avivi,
S. Polak‐Charcon,
I. Barshack,
N. Amariglio,
G. Rechavi,
J. van der Werff Ten Bosch,
Y. Anikster,
C. Klein,
W. Gahl,
R. Somech
|
6 |
2013 |
6
🐜
|
|
🐜
|
Mutations in STN1 cause Coats plus syndrome and are associated with genomic and telomere defects
33 auth.
A. Simon,
A. Lev,
Yong Zhang,
B. Weiss,
A. Rylova,
E. Eyal,
N. Kol,
O. Barel,
Keren Cesarkas,
M. Soudack,
Noa Greenberg-Kushnir,
M. Rhodes,
D. Wiest,
G. Schiby,
I. Barshack,
...
S. Katz,
E. Pras,
H. Poran,
H. Reznik‐Wolf,
E. Ribakovsky,
C. Simòn,
Wadi Hazou,
Y. Sidi,
A. Lahad,
Hagar Katzir,
S. Sagie,
Haifa A Aqeilan,
Galina Glousker,
N. Amariglio,
Y. Tzfati,
S. Selig,
G. Rechavi,
R. Somech
|
6 |
2016 |
6
🐜
|
|
🐜
|
Cytogenetics of extramedullary manifestations in multiple myeloma
18 auth.
Lisa Billecke,
E. M. Murga Penas,
A. May,
M. Engelhardt,
A. Nagler,
M. Leiba,
G. Schiby,
N. Kröger,
J. Zustin,
A. Marx,
...
J. Matschke,
M. Tiemann,
E. Goekkurt,
H. Heidtmann,
E. Vettorazzi,
J. Dierlamm,
C. Bokemeyer,
G. Schilling
|
6 |
2013 |
6
🐜
|
|
🐜
|
Novel Proangiogenic Effect of Factor XIII Associated With Suppression of Thrombospondin 1 Expression
8 auth.
R. Dardik,
A. Solomon,
J. Loscalzo,
R. Eskaraev,
Anna Bialik,
I. Goldberg,
...
G. Schiby,
A. Inbal
|
6 |
2003 |
6
🐜
|
|
🐜
|
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy
13 auth.
D. Gratzinger,
Shuchun Zhao,
R. Tibshirani,
E. Hsi,
C. Hans,
B. Pohlman,
M. Bast,
A. Avigdor,
G. Schiby,
A. Nagler,
...
G. Byrne,
I. Lossos,
Y. Natkunam
|
6 |
2008 |
6
🐜
|
|
🐜
|
Aging affects B‐cell antigen receptor repertoire diversity in primary and secondary lymphoid tissues
13 auth.
Hilla Tabibian‐Keissar,
L. Hazanov,
G. Schiby,
N. Rosenthal,
Aviya Rakovsky,
Miri Michaeli,
G. Shahaf,
Yishai Pickman,
K. Rosenblatt,
D. Melamed,
...
D. Dunn-Walters,
R. Mehr,
I. Barshack
|
6 |
2016 |
6
🐜
|
|
🐜
|
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.
12 auth.
Tamar Fisher,
H. Golan,
G. Schiby,
S. Pri-Chen,
R. Smoum,
I. Moshe,
...
N. Peshes-Yaloz,
A. Castiel,
D. Waldman,
R. Gallily,
R. Mechoulam,
A. Toren
|
5 |
2016 |
5
🐜
|
|
🐜
|
Disruption of Thrombocyte and T Lymphocyte Development by a Mutation in ARPC1B
20 auth.
R. Somech,
A. Lev,
Y. Lee,
A. Simon,
O. Barel,
G. Schiby,
C. Avivi,
I. Barshack,
M. Rhodes,
Jiejing Yin,
...
Minshi Wang,
Yibin Yang,
J. Rhodes,
Nufar Marcus,
B. Garty,
J. Stein,
N. Amariglio,
G. Rechavi,
D. Wiest,
Yong Zhang
|
5 |
2017 |
5
🐜
|
